Cullinan Therapeutics (CGEM) Payables (2020 - 2023)
Historic Payables for Cullinan Therapeutics (CGEM) over the last 4 years, with Q3 2023 value amounting to $2.4 million.
- Cullinan Therapeutics' Payables changed 0.0% to $2.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $2.4 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $2.7 million for FY2022, which is 1606.18% down from last year.
- Cullinan Therapeutics' Payables amounted to $2.4 million in Q3 2023, which was down 0.0% from $2.5 million recorded in Q2 2023.
- In the past 5 years, Cullinan Therapeutics' Payables ranged from a high of $9.7 million in Q4 2020 and a low of $1.5 million during Q2 2021
- Over the past 4 years, Cullinan Therapeutics' median Payables value was $2.6 million (recorded in 2022), while the average stood at $3.5 million.
- In the last 5 years, Cullinan Therapeutics' Payables soared by 10523.18% in 2022 and then plummeted by 6779.26% in 2023.
- Quarter analysis of 4 years shows Cullinan Therapeutics' Payables stood at $9.7 million in 2020, then crashed by 67.26% to $3.2 million in 2021, then decreased by 16.06% to $2.7 million in 2022, then dropped by 9.62% to $2.4 million in 2023.
- Its Payables was $2.4 million in Q3 2023, compared to $2.5 million in Q2 2023 and $2.0 million in Q1 2023.